The North America colorectal cancer screening tests market was valued at USD 5.94 billion in 2023. The market is further projected to grow at a CAGR of 5.6% between 2024 and 2032, reaching an estimated value of USD 9.78 billion by 2032. The growth is fueled by increasing awareness about early cancer